.png)
Leadership appointment demonstrating Zigzag’s commitment to the expansion of its global quality services.
Cambridge, July 11, 2024 – Zigzag Associates Ltd, a leading provider of sponsor research and development quality and compliance consulting services, is thrilled to announce the appointment of Felix Böhles as the company's Chief Financial Officer (CFO).
In his new role as CFO, Böhles will be responsible for leading the company's financial strategy, operations and reporting. He will work closely with the executive team in partnership to expand the global footprint within the quality space.
"I am thrilled to appoint Felix to our executive team," said Julie Beal, CEO. "His depth of experience will be key in driving our financial strategy. His proven track record in senior finance positions will facilitate our accelerated growth and expansion of best-in-class service to our clients."
Felix expressed his excitement about his appointment stating, "I am honoured to join Zigzag at such an exciting time and be part of the growth journey. Our commitment to providing best in class quality on a global scale will be a game changer in ensuring our clients see a lasting, streamlined impact on their quality programs. I look forward to leveraging my finance and compliance experience to contribute to the company's growth and further strengthen its position as a leader in the pharmaceutical service provider industry."
About Zigzag Associates:
Zigzag is a United Kingdom headquartered consulting firm, with global office locations, specializing in pharmaceutical research quality and compliance. With a team of experienced professionals and deep industry expertise, we provide comprehensive consulting services to pharmaceutical companies, helping them navigate regulatory requirements, optimize quality systems, and ensure compliance throughout the drug development process.
For more information, please contact us here: https://www.zigzagassociates.com/contact-us
Comments